/Companies

Advanced Catheter Therapies

11 known investors

Find your way into Advanced Catheter Therapies

Sign up to see every warm intro you have to Advanced Catheter Therapies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced Catheter Therapies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.

Founders & leadership

PJ
Paul J. FitzpatrickChief Executive Officer

Investors · 11

Also in the syndicate · 7

ACT I Investments, LLCBlank Slate Venture Fund II, LLCDeMoss Alternative Opportunities Fund, LPINCITE Co-Investment FundInnova Fund II LPMaclellan FoundationToray Industries, Inc.

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries BMar 2015

    Toray Industries, Inc.

    Source ↗
  • Undisclosed amountSeries BAug 2014

    ACT I Investments, LLC, Blank Slate Venture Fund II, LLC, Chattanooga Renaissance Fund, DeMoss Alternative Opportunities Fund, LP, INCITE Co-Investment Fund, Innova Fund II LP, Maclellan Foundation

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Merit MedicalMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
BDBD is a global medical technology company developing devices, systems, and solutions for medication administration, diagnostics, connected care, biopharmaceutical manufacturing, and interventional procedures. The company serves healthcare providers, laboratories, and biopharmaceutical manufacturers across diagnostics, drug delivery, surgical care, and patient monitoring.
AngiodynamicsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.

Companies working in the same space as Advanced Catheter Therapies.

In the news

Frequently asked questions

What does Advanced Catheter Therapies do?
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
Who are Advanced Catheter Therapies's investors?
Advanced Catheter Therapies's investors include Chattanooga Renaissance Fund, Innova Memphis, Inc., Solas BioVentures, Blank Slate Ventures.